Insider · CIK 0001228879

MACDONALD JOHN R

Reports to the SEC for 1 company · BLOOMINGTON, MN

sec.gov

Transactions

Companies

Filings

CIK

0001228879

Forms 4 and 5

Insider transactions

37 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2005-07-15	MGI PHARMA INCEmployee Stock Option - Right to BuyA Award	Sr. VP, Research & Development	AAward	+15K sh	—	—	15,000
2005-07-15	MGI PHARMA INCA Award	Sr. VP, Research & Development	AAward	+3,000 sh	—	—	14,676
2005-02-15	MGI PHARMA INCS Sale	Sr. VP, Research & Development	SSale	−20.3K sh	$25.03	−$507K	11,676
2005-02-15	MGI PHARMA INCEmployee Stock Option-Right to BuyM Exercise/Conversion	Sr. VP, Research & Development	MExercise/Conversion	−250 sh	—	—	0
2005-02-15	MGI PHARMA INCEmployee Stock Option-Right to BuyM Exercise/Conversion	Sr. VP, Research & Development	MExercise/Conversion	−20K sh	—	—	0
2005-02-15	MGI PHARMA INCM Exercise/Conversion	Sr. VP, Research & Development	MExercise/Conversion	+250 sh	$2.29	+$572.2	11,926
2005-02-15	MGI PHARMA INCM Exercise/Conversion	Sr. VP, Research & Development	MExercise/Conversion	+20K sh	$1.97	+$39.4K	31,926
2005-02-14	MGI PHARMA INCM Exercise/Conversion	Sr. VP, Research & Development	MExercise/Conversion	+7,750 sh	$2.41	+$18.6K	19,426
2005-02-14	MGI PHARMA INCS Sale	Sr. VP, Research & Development	SSale	−10K sh	$25.00	−$250K	11,676
2005-02-14	MGI PHARMA INCEmployee Stock Option-Right to BuyM Exercise/Conversion	Sr. VP, Research & Development	MExercise/Conversion	−2,250 sh	—	—	250
2005-02-14	MGI PHARMA INCEmployee Stock Option-Right to BuyM Exercise/Conversion	Sr. VP, Research & Development	MExercise/Conversion	−7,750 sh	—	—	0
2005-02-14	MGI PHARMA INCM Exercise/Conversion	Sr. VP, Research & Development	MExercise/Conversion	+2,250 sh	$2.29	+$5,149.8	21,676
2004-05-26	MGI PHARMA INCM Exercise/Conversion	Sr. VP, Research & Development	MExercise/Conversion	+3,750 sh	$4.38	+$16.4K	9,588
2004-05-26	MGI PHARMA INCM Exercise/Conversion	Sr. VP, Research & Development	MExercise/Conversion	+7,750 sh	$4.75	+$36.8K	17,338
2004-05-26	MGI PHARMA INCEmployee Stock Option - Right to BuyM Exercise/Conversion	Sr. VP, Research & Development	MExercise/Conversion	−3,750 sh	$4.38	−$16.4K	0
2004-05-26	MGI PHARMA INCS Sale	Sr. VP, Research & Development	SSale	−16K sh	$63.40	−$1.02M	5,838
2004-05-26	MGI PHARMA INCM Exercise/Conversion	Sr. VP, Research & Development	MExercise/Conversion	+650 sh	$3.38	+$2,193.75	21,863
2004-05-26	MGI PHARMA INCM Exercise/Conversion	Sr. VP, Research & Development	MExercise/Conversion	+3,875 sh	$3.75	+$14.5K	21,213
2004-05-26	MGI PHARMA INCEmployee Stock Option - Right to BuyM Exercise/Conversion	Sr. VP, Research & Development	MExercise/Conversion	−3,875 sh	$3.75	−$14.5K	0
2004-05-26	MGI PHARMA INCEmployee Stock Option - Right to BuyM Exercise/Conversion	Sr. VP, Research & Development	MExercise/Conversion	−650 sh	$3.38	−$2,193.75	0
2004-05-26	MGI PHARMA INCEmployee Stock Option - Right to BuyM Exercise/Conversion	Sr. VP, Research & Development	MExercise/Conversion	−7,750 sh	$4.75	−$36.8K	0
2004-01-20	MGI PHARMA INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP, Research & Development	MExercise/Conversion	−1,750 sh	$5.75	−$10.1K	0
2004-01-20	MGI PHARMA INCM Exercise/Conversion	Sr. VP, Research & Development	MExercise/Conversion	+1,750 sh	$5.75	+$10.1K	7,588
2004-01-20	MGI PHARMA INCS Sale	Sr. VP, Research & Development	SSale	−1,750 sh	$46.24	−$80.9K	5,838
2004-01-20	MGI PHARMA INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP, Research & Development	MExercise/Conversion	−1,750 sh	$5.75	−$10.1K	0
2004-01-20	MGI PHARMA INCM Exercise/Conversion	Sr. VP, Research & Development	MExercise/Conversion	+1,750 sh	$5.75	+$10.1K	7,588
2004-01-20	MGI PHARMA INCS Sale	Sr. VP, Research & Development	SSale	−1,750 sh	$46.24	−$80.9K	5,838
2003-11-20	MGI PHARMA INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP, Research & Development	MExercise/Conversion	−3,000 sh	$10.50	−$31.5K	3,000
2003-11-20	MGI PHARMA INCS Sale	Sr. VP, Research & Development	SSale	−6,000 sh	$37.64	−$226K	5,838
2003-11-20	MGI PHARMA INCM Exercise/Conversion	Sr. VP, Research & Development	MExercise/Conversion	+3,000 sh	$5.75	+$17.3K	11,838
2003-11-20	MGI PHARMA INCM Exercise/Conversion	Sr. VP, Research & Development	MExercise/Conversion	+3,000 sh	$10.50	+$31.5K	8,838
2003-11-20	MGI PHARMA INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP, Research & Development	MExercise/Conversion	−3,000 sh	$5.75	−$17.3K	4,750
2003-07-24	MGI PHARMA INCCommon StockA Award	Sr. VP, Research & Development	AAward	+20K sh	$26.61	+$532K	20,000
2003-07-24	MGI PHARMA INCLimited Stock Appreciation RightA Award	Sr. VP, Research & Development	AAward	+20K sh	$26.61	+$532K	20,000
2003-07-24	MGI PHARMA INCCommon StockA Award	Sr. VP, Research & Development	AAward	+25K sh	$26.61	+$665K	25,000
2003-07-24	MGI PHARMA INCCommon StockA Award	Sr. VP, Research & Development	AAward	+25K sh	$26.61	+$665K	25,000
2003-07-24	MGI PHARMA INCLimited Stock Appreciation RightA Award	Sr. VP, Research & Development	AAward	+25K sh	$26.61	+$665K	25,000

Recent filings

Accepted (ET)
Jul 184
MGI PHARMA INC0001181431-05-040685
SEC(opens sec.gov)
Feb 154
MACDONALD JOHN R0001271137-05-000014
SEC(opens sec.gov)
May 264
MACDONALD JOHN R0001271137-04-000039
SEC(opens sec.gov)

Companies

MGI PHARMA INCSr. VP, Research & Development

Address

MGI PHARMA, INC. 5775 WEST OLD SHAKOPEE ROAD, SUITE 100

BLOOMINGTON, MN, 55437